MiniMed Group, Inc. (MMED) has a MoatMap StockRank of 36/100 based on Quality (48/100), Value (41/100), and Momentum (34/100) factor scores. The current signal is HOLD. The company lacks a proven commercial business model, stable cash flows, or alignment with our high-conviction macro themes, making it too speculative for a concentrated quality portfolio.
Minimed Group, Inc. is a healthcare company focused on the development and commercialization of medical products or services, likely within a specialized therapeutic area or medical device segment. The company aims to differentiate through innovation and targeted solutions that address specific patient needs. Its success hinges on clinical validation, regulatory approvals, and effective market penetration in a competitive healthcare landscape.
| Price | $14.26 |
| Market Cap | $3.2B |
| P/E (Forward) | 16.63 |
| Price/Book | 0.91 |
| Return on Invested Capital | -1.0% |
| Debt/Equity | 1.76 |
| Gross Margin | 56.7% |
| Operating Margin | -11.0% |
| Revenue Growth | 15.0% |
MiniMed Group, Inc. operates in the Health Information Services industry, part of the Healthcare sector (United States).